Sontag Advisory »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Sontag Advisory

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $25k 27k 0.92

More positions owned by Sontag Advisory

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Aon Shs Cl A (AON)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Growth Etf (VUG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Sontag Advisory

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Jpmorgan Chase & Co
Highbridge Capital Management
DG Capital Management
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Bnp Paribas Investment Partners
State of Wisconsin Investment Board
Palisade Capital Management
FMR
Advent Capital Management
Financial Consulate
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1